{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:38:16Z","timestamp":1790653096567,"version":"4.1.0"},"reference-count":43,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Non-cardiac comorbidities (NCCs) are highly prevalent among patients hospitalized for acute heart failure (HF). However, data from sub-Saharan Africa (SSA) on their distribution across HF phenotypes and association with in-hospital outcomes remain limited. Methods: We prospectively enrolled adults hospitalized with acute HF at a tertiary centre in South Africa between February and November 2023. Ten NCCs were assessed and patients were categorized according to comorbidity burden. The primary outcomes were all-cause in-hospital mortality and length of stay. Multivariable regression and sensitivity analyses were performed to identify predictors of outcomes. Results: Of the 406 patients (mean age 54.9 \u00b1 15.8 years; 51% women), HF with reduced ejection fraction (HFrEF) accounted for 63%, HF with mildly reduced ejection fraction (HFmrEF) for 15%, and HF with preserved ejection fraction (HFpEF) for 21%. The most common NCCs were diabetes (47%), chronic kidney disease (CKD) (46%), obesity (45%), and anaemia (33%). Two-thirds had \u22652 NCCs. The median hospital stay was 8 days (IQR: 5\u201312) and in-hospital mortality was 3.4% (p &gt; 0.05 across NCC groups). Higher heart rate predicted longer hospitalization, while renin angiotensin system inhibitor (RASi) therapy was associated with shorter stay. Lower Kansas City Cardiomyopathy Questionnaire (KCCQ) score (adjusted odds ratio [aOR] 1.009; 95% confidence interval [CI]: 1.003\u20131.015) and higher log-transformed NT-proBNP were independently associated with increased in-hospital mortality (aOR 1.85; 95% CI: 1.07\u20133.50; p = 0.026). Total comorbidity burden was not independently associated with length of stay or in-hospital mortality. Conclusions: Non-cardiac comorbidities are common in acute HF in SSA, and functional status and clinical markers were the strongest predictors of length of stay and in-hospital mortality.<\/jats:p>","DOI":"10.3390\/jcm15062202","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:06:22Z","timestamp":1773414382000},"page":"2202","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Non-Cardiac Comorbidities in Acute Heart Failure: Phenotype-Specific Insights from Sub-Saharan Africa"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5942-2668","authenticated-orcid":false,"given":"Umar G.","family":"Adamu","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Nel","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Confidence","family":"Makgoro","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzi","family":"Maseko","sequence":"additional","affiliation":[{"name":"Nutrition and Hypertension Laboratory, Department of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7210-1447","authenticated-orcid":false,"given":"Nqoba","family":"Tsabedze","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: A comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.jacc.2017.08.074","article-title":"Heart Failure with Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes","volume":"70","author":"Shah","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/eurjpc\/zwad151","article-title":"Comprehensive characterization of non-cardiac comorbidities in acute heart failure: An analysis of ESC-HFA EURObservational Research Programme Heart Failure Long-Term Registry","volume":"30","author":"Chioncel","year":"2023","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijcard.2020.04.068","article-title":"Comorbidities and cause-specific outcomes in heart failure across the ejection fraction spectrum: A blueprint for clinical trial design","volume":"313","author":"Savarese","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijcard.2018.04.001","article-title":"Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction","volume":"271","author":"Streng","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"020409","DOI":"10.7189\/jogh.09.020409","article-title":"Non-communicable diseases in sub-Saharan Africa: A scoping review of large cohort studies","volume":"9","author":"Mudie","year":"2019","journal-title":"J. Glob. Health"},{"key":"ref_8","first-page":"707","article-title":"Cardiovascular disease in HIV infection in South Africa: Not just a Western problem","volume":"16","author":"Ntusi","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/archinternmed.2012.3310","article-title":"The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries","volume":"172","author":"Damasceno","year":"2012","journal-title":"Arch. Intern. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ehf2.12903","article-title":"Clinical characteristics and outcomes of black African heart failure patients with preserved, mid-range, and reduced ejection fraction: A post hoc analysis of the THESUS-HF registry","volume":"8","author":"Dzudie","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1002\/ehf2.15394","article-title":"Clinical characteristics and outcomes of adults with acute heart failure in a South African teaching hospital","volume":"12","author":"Adamu","year":"2025","journal-title":"ESC Heart Fail."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","article-title":"Recommendations for chamber quantification: A report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology","volume":"18","author":"Lang","year":"2005","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/CIRCULATIONAHA.120.047019","article-title":"Temporal Trends in Prevalence and Prognostic Implications of Comorbidities Among Patients with Acute Decompensated Heart Failure: The ARIC Study Community Surveillance","volume":"142","author":"Pandey","year":"2020","journal-title":"Circulation"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Huo, X., Zhang, L., Bai, X., He, G., Li, J., Miao, F., Lu, J., Liu, J., Zheng, X., and Li, J. (2022). Impact of Non-cardiac Comorbidities on Long-Term Clinical Outcomes and Health Status After Acute Heart Failure in China. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.883737"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ejhf.3112","article-title":"The role of multimorbidity in patients with heart failure across the left ventricular ejection fraction spectrum: Data from the Swedish Heart Failure Registry","volume":"26","author":"Tomasoni","year":"2024","journal-title":"Eur. J. Heart Fail."},{"key":"ref_16","first-page":"117","article-title":"Heart failure in sub-Saharan Africa: Etiology, diagnosis, and management","volume":"24","author":"Ntsekhe","year":"2013","journal-title":"Cardiovasc. J. Afr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/hrt.2010.206938","article-title":"Incidence and characteristics of newly diagnosed heart failure in urban African patients: The Heart of Soweto Study","volume":"96","author":"Sliwa","year":"2010","journal-title":"Heart"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e665","DOI":"10.1016\/S2214-109X(17)30196-1","article-title":"Global mortality variations in patients with heart failure: Results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study","volume":"5","author":"Dokainish","year":"2017","journal-title":"Lancet Glob. Health"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Taderegew, M.M., Wondie, A., Terefe, T.F., Tarekegn, T.T., GebreEyesus, F.A., Mengist, S.T., Amlak, B.T., Emeria, M.S., Timerga, A., and Zegeye, B. (2023). Anemia and its predictors among chronic kidney disease patients in Sub-Saharan African countries: A systematic review and meta-analysis. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0280817"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Bae, J.P., Kallenbach, L., Nelson, D.R., Lavelle, K., Winer-Jones, J.P., Bonafede, M., and Murakami, M. (2024). Obesity and metabolic syndrome in patients with heart failure with preserved ejection fraction: A cross-sectional analysis of the Veradigm Cardiology Registry. BMC Endocr. Disord., 24.","DOI":"10.1186\/s12902-024-01589-2"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.mayocp.2023.07.008","article-title":"Obesity, Cardiorenal Comorbidities, and Risk of Hospitalization in Patients with Heart Failure with Preserved Ejection Fraction","volume":"98","author":"Morgen","year":"2023","journal-title":"Mayo Clin. Proc."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: Comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1056\/NEJMcp1511175","article-title":"Heart Failure with Preserved Ejection Fraction","volume":"375","author":"Redfield","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): A multinational, open-label, randomised, trial","volume":"400","author":"Mebazaa","year":"2022","journal-title":"Lancet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin\u2013neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"PARADIGM-HF Investigators and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/ejhf.3044","article-title":"Calcium channel blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction","volume":"25","author":"Matsumoto","year":"2023","journal-title":"Eur. J. Heart Fail."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e005266","DOI":"10.1161\/CIRCHEARTFAILURE.118.005266","article-title":"Thyroid Dysfunction in Heart Failure and Cardiovascular Outcomes","volume":"11","author":"Kannan","year":"2018","journal-title":"Circ. Heart Fail."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","article-title":"Thyroid disease and the heart","volume":"116","author":"Klein","year":"2007","journal-title":"Circulation"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10557-019-06870-4","article-title":"The Role of Thyroid Hormones in Heart Failure","volume":"33","author":"Vale","year":"2019","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s42000-020-00208-8","article-title":"Relationship of thyroid dysfunction with cardiovascular diseases: Updated review on heart failure progression","volume":"19","author":"Gaber","year":"2020","journal-title":"Hormones"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"466","DOI":"10.5603\/EP.a2020.0052","article-title":"Thyroid gland dysfunction and its effect on the cardiovascular system: A comprehensive review of the literature","volume":"71","author":"Ahmadi","year":"2020","journal-title":"Endokrynol. Pol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e1874","DOI":"10.1016\/S2214-109X(23)00408-4","article-title":"Multimorbidity in patients with acute heart failure across world regions and country income levels (REPORT-HF): A prospective, multicentre, global cohort study","volume":"11","author":"Gerhardt","year":"2023","journal-title":"Lancet Glob. Health"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Lee, K.S., Park, D.I., Lee, J., Oh, O., Kim, N., and Nam, G. (2023). Relationship between comorbidity and health outcomes in patients with heart failure: A systematic review and meta-analysis. BMC Cardiovasc. Disord., 23.","DOI":"10.1186\/s12872-023-03527-x"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Murru, V., Belfiori, E., Sestu, A., Casanova, A., Serra, C., and Scuteri, A. (2025). Patterns of comorbidities differentially impact on in-hospital outcomes in heart failure patients. BMC Geriatr., 25.","DOI":"10.1186\/s12877-025-06002-8"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Siddikatou, D., Mandeng, M., Linwa, E., Ndobo, V., Nkoke, C., Mouliom, S., Ndom, M.S., Abas, A., and Kamdem, F. (2025). Heart failure outcomes in Sub-Saharan Africa: A scoping review of recent studies conducted after the 2022 AHA\/ACC\/HFSA guideline release. BMC Cardiovasc. Disord., 25.","DOI":"10.1186\/s12872-025-04756-y"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/CIRCHEARTFAILURE.113.000359","article-title":"Comparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction","volume":"6","author":"Joseph","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Heart rate as a risk factor in chronic heart failure (SHIFT): The association between heart rate and outcomes in a randomised placebo-controlled trial","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1177\/2047487318780035","article-title":"Efficacy of Renin-Angiotensin System Inhibitors for Patients with Heart Failure with Preserved Ejection Fraction and Mild to Moderate Chronic Kidney Disease","volume":"25","author":"Tsujimoto","year":"2018","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"132190","DOI":"10.1016\/j.ijcard.2024.132190","article-title":"Renin-Angiotensin System Inhibitors for Patients with Mild or Moderate Chronic Kidney Disease and heart failure with mildly reduced or preserved ejection fraction","volume":"409","author":"Takeuchi","year":"2024","journal-title":"Int. J. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jchf.2019.02.009","article-title":"Medical Management of Heart Failure with Reduced Ejection Fraction and Concurrent Renal Dysfunction","volume":"7","author":"Hein","year":"2019","journal-title":"JACC Heart Fail."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1002\/ehf2.15300","article-title":"Length of stay and prior heart failure admission in frailty and heart failure: A systematic review and meta-analysis","volume":"12","author":"Prokopidis","year":"2025","journal-title":"ESC Heart Fail."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejim.2019.12.030","article-title":"The age-adjusted Charlson comorbidity index: A significant predictor of clinical outcome in patients with heart failure","volume":"73","author":"Shuvy","year":"2020","journal-title":"Eur. J. Intern. Med."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/6\/2202\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:19:46Z","timestamp":1773415186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/6\/2202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["jcm15062202"],"URL":"https:\/\/doi.org\/10.3390\/jcm15062202","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]}}}